Denali Therapeutics Inc

Home » Denali Therapeutics Inc

IPO

Denali Therapeutics Inc

Their goal is to discover and develop therapeutics to defeat degeneration.

Symbol

DNLI

Price Range
TBD

Anticipated Shares
13,880,000

Effective Date
December 8, 2017

Underwriters
Goldman Sachs, J.P. Morgan, Morgan Stanley

To view the prospectus for Denali Therapeutics Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253